TY - JOUR T1 - Whole Genome Sequencing Analysis of Spike D614G Mutation Reveals Unique SARS-CoV-2 Lineages of B.1.524 and AU.2 in Malaysia JF - medRxiv DO - 10.1101/2021.08.11.21261902 SP - 2021.08.11.21261902 AU - Ummu Afeera Zainulabid AU - Aini Syahida Mat Yassim AU - Sharmeen Nellisa Soffian AU - Mohamad Shafiq Mohd Ibrahim AU - Norhidayah Kamarudin AU - Mohd Nazli Kamarulzaman AU - How Soon Hin AU - Hajar Fauzan Ahmad Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/18/2021.08.11.21261902.abstract N2 - The SARS-CoV-2 has spread throughout the world since its discovery in China, and Malaysia is no exception. WGS has been a crucial approach in studying the evolution and genetic diversity of SARS-CoV-2 in the ongoing pandemic, and while an exceptional number of SARS-CoV-2 complete genomes have since been submitted to GISAID and NCBI, there is a scarcity of data from Malaysia. This study aims to report new Malaysian lineages responsible for the sustained spikes in COVID-19 cases during the third wave of the pandemic. Patients whose nasopharyngeal and oropharyngeal swabs were confirmed positive by real-time RT-PCR with Ct-value < 25 were chosen for WGS. The 10 SARS-CoV-2 isolates obtained were then sequenced, characterized and analyzed, including 1356 sequences of the dominant lineages of D614G variant currently circulating throughout Malaysia. The prevalence of clade GH and G formed strong ground of the discovery of two Malaysian lineages that caused sustained spikes of cases locally. Statistical analysis on the association of gender and age group with Malaysian lineages revealed a significant association (p < 0.05). Phylogenetic analysis revealed dispersion of 41 lineages, for which 22 lineages are still active. Mutational analysis observed unique G1223C missense mutation in Transmembrane Domain of Spike protein. Thus, calls for the large-scale WGS analysis of strains found around the world for greater understanding of viral evolution and genetic diversity especially in addressing the question of the effect of deleterious substitution mutation in transmembrane region of Spike protein.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received funding for this work from the Ministry of Higher Education Malaysia and Sultan Ahmad Shah Medical Centre @ IIUM for supporting this work. Hajar Fauzan Ahmad awarded for FRGS/1/2019/WAB13/UMP/03/1 and Ummu Afeera Zainulabid is Principal Investigator for SRG21-040-0040, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval (IREC 2021-080) was obtained from IIUM Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe sequences from WGS effort of this study were deposited in GenBank under the accession numbers MW079428.1 and MZ443817.1 to MZ443824.1. The accession numbers in the NCBI Sequence Read Archive (SRA) are SRP286590 and SRP324679. All the SARS-CoV-2 with D614G mutation of Malaysia were collated from GISAID (https://www.gisaid.org/). ER -